#3164
Yu De-Chao
Overview
- Source of Wealth
- pharmaceuticals
- Industry
- Healthcare
- Residence
- Suzhou, Jiangsu
- Education
- Chinese Academy of Sciences (Ph.D)
Assets
- Innovent Biologics88,658,000 shares @ --1801-HK
Biography
Yu De-Chao, also known as Michael Yu, is the chairman and CEO of Innovent Biologics, a China-headquartered biotech company.
Innovent went public at the Hong Kong Stock Exchange in 2018.
Yu holds a PhD in molecular genetics from the Chinese Academy of Sciences.
Yu had a postdoc position in pharmaceutical chemistry at the University of California San Francisco from 1993 to 1996.